We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Mass Spectrometry Imaging Used to Process Biologic “Big Data”

By LabMedica International staff writers
Posted on 01 Dec 2014
Print article
The vast amounts of data that are generated by the latest scientific instruments are leading to significant scientific discoveries, but only when scientists can effectively process that data. Big data represents both an opportunity and a challenge for scientists. This is especially the case for analytic scientists studying biologic materials using a fairly new technique known as mass spectrometry imaging (MSI). Help has arrived from a recent project, however, called Computis, which has a range of new tools for effectively processing MSI data.

MSI is a form of mass spectrometry (MS) that enables both spatial and mass spectrometric analysis by measuring the masses of compounds at specific locations on the surface of a solid sample. MSI can, therefore, construct a visual image of its chemical composition. Various MSI techniques are available, including matrix-assisted laser desorption/ionization (MALDI), secondary ion MS (SIMS) and desorption electrospray ionization (DESI), but they all generate huge amounts of data.

Although software tools are available for processing this information, they tend to be produced by the manufacturers of the MSI instruments and therefore each uses diverse data formats, making it difficult to combine and process data generated by different instruments. Computis was set up by the European Commission in 2006 to overcome this hurdle by developing a new generation of flexible and efficient tools for processing any MSI data. It involved academic and industrial teams from across Europe, including the French Atomic Energy Commission and the Swiss pharmaceutical giant Novartis (Basel, Switzerland). The project was completed in 2010 and the main outputs have now been described November 2014 in an article in the European Journal of Mass Spectrometry (EJMS).

The project members rapidly figured out that their first task should be to develop a common format for MSI data that all the other data formats could be converted into, which led to the imzML data format. This format divides MSI data into two separate files: the mass data are stored in a binary file to ensure proficient storage, while metadata such as instrumental parameters and sample details are stored in an XML file. The members also developed several tools for translating MSI data in other formats into the imzML format.

The project then developed several tools specially designed to work with the imzML format. This included two tools for processing and displaying MSI data, Data Cube Explorer and SpectViewer, and a tool called EasyReg2D for incorporating MSI data with image data from other analytic instruments, including microscopes. Furthermore, the researchers adapted an existing MSI processing tool known as BioMap to work with data in the imzML format.

According to the investigators, this project has been successful in greatly expanding the tools available for processing MSI data, helping to ensure big data becomes an opportunity for scientists instead of remaining a challenge.

Related Links:

Novartis


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Unit-Dose Packaging solution
HLX
New
Flu Test
ID NOW Influenza A & B 2
New
Thyroid ELISA Kit
AESKULISA a-TPO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.